Medtech acceleration
We are serial entrepreneurs using a unique model to discover and nurture ground-breaking ideas for therapeutic medical devices.
We create and build companies to turn the best of these ideas into tools that practitioners can use to save and improve patients’ lives.
Close | Fund | AMT |
---|---|---|
2008 | MD Start I | €8.2 million |
2015 | MD Start II | €10.3 million |
2019 | Sofinnova MD Start III | €63 million |
Close: 2008
Fund: MD Start I
AMT: €8.2 million
Close: 2015
Fund: MD Start II
AMT: €10.3 million
Close: 2019
Fund: Sofinnova MD Start III
AMT: €63 million
“We’re not trying to find ways to use new technologies in medicine. We start from the clinical need. From there, we try to find technologies that will help us develop products that are going to solve that need.”
"We're not up there in the balcony giving the thumbs up or thumbs down as entrepreneurs make their pitches. We build the story; we bring in the necessary assets; we create the company, often from scratch."
The
Team
Anne Osdoit
Partner, Sofinnova Partners MD Start Strategy
Lukas Guenther
Partner, Sofinnova Partners MD Start Strategy
Cécile Dupont
Principal, Program Director, Sofinnova Partners MD Start Strategy
Marion Gasperment
Associate, Program Manager, Sofinnova Partners MD Start Strategy
Gérard Hascoët
Venture Partner, Sofinnova Partners
Companies
MD Start
Advanced Perfusion Diagnostics
Capital & MD Start
CorWave
MD Start
Endoron Medical
MD Start
Gradient Denervation Technologies
MD Start
HEPTA Medical
MD Start
Julier Medical
MD Start & Crossover
LimFlow
Capital & MD Start
May Health
MD Start
Moon Surgical
MD Start
preCARDIA
Capital & MD Start
SafeHeal
0 results
Related News
Julier Medical raises €3 million in seed financing from Sofinnova Partners to treat patients with acute ischemic stroke
May Health completes treatment of five participants in U.S. feasibility study of its Ovarian Rebalancing treatment for PCOS-related infertility
Moon Surgical completes first-in-human clinical study with its Maestro™ Surgical Robotics System
Moon Surgical receives first FDA 510(k) clearance for its Maestro(TM) Surgical Robotics System
Moon Surgical announces appointment of Mark Toland as Independent Board Member